Susceptible and protective eNOS haplotypes in hypertensive black and white subjects

Atherosclerosis

Volumn 186, Issue 2, 2006, Pages 428-432

  Sandrim, Valeria Cristina ^a   Coelho, Eduardo Barbosa ^a   Nobre, Fernando ^a   Arado, Gustavo Marin ^a   Lanchote, Vera Lucia ^a   Tanus Santos, Jose Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endothelial nitric oxide synthase; Ethnicity; Haplotypes; Hypertension; Nitric oxide; Polymorphism

Indexed keywords

ASPARAGINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMINE;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNOLOGY; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; INTRON; MALE; NEGRO; PRIORITY JOURNAL; PROMOTER REGION; TANDEM REPEAT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; ISOENZYMES; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33646405178     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.08.003     Document Type: Article

References (26)

1. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84 (1987) 9265-9269
2. Thomas G.D., Zhang W., and Victor R.G. Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. Jama 285 (2001) 2055-2057
3. Miyamoto Y., Saito Y., Kajiyama N., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1998) 3-8
4. Shoji M., Tsutaya S., Saito R., Takamatu H., and Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 66 (2000) 2557-2562
5. Uwabo J., Soma M., Nakayama T., and Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 11 (1998) 125-128
6. Jachymova M., Horky K., Bultas J., et al. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 284 (2001) 426-430
7. Benjafield A.V., and Morris B.J. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 13 (2000) 994-998
8. Karvonen J., Kauma H., Kervinen K., et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 251 (2002) 102-110
9. Tsujita Y., Baba S., Yamauchi R., et al. Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: the Suita study. J Hypertens 19 (2001) 1941-1948
10. -786C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39 (2002) 919-922
11. Cardon L.R., and Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2 (2001) 91-99
12. Tanus-Santos J.E., Desai M., and Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11 (2001) 719-725
13. Marroni A.S., Metzger I.F., Souza-Costa D.C., et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase (eNOS) genetic polymorphisms. Nitric Oxide 12 (2005) 177-182
14. Hassan A., Gormley K., O'Sullivan M., et al. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35 (2004) 654-659
15. Crawford D.C., and Nickerson D.A. Definition and clinical importance of haplotypes. Annu Rev Med 56 (2005) 303-320
16. Tanus-Santos J.E., Desai M., Deak L.R., et al. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12 (2002) 407-413
17. Nagassaki S., Metzger I.F., Souza-Costa D.C., et al. eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb Res 115 (2005) 375-379
18. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2001) 233-237
19. Sing C.F., Stengard J.H., and Kardia S.L. Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23 (2003) 1190-1196
20. Wang J., Dudley D., and Wang X.L. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 22 (2002) e1-e4
21. -786C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
22. -786C mutation associated with coronary spastic angina. Hum Mol Genet 9 (2000) 2629-2637
23. Golser R., Gorren A.C., Mayer B., and Schmidt K. Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric Oxide 8 (2003) 7-14
24. Fairchild T.A., Fulton D., Fontana J.T., Gratton J.P., McCabe T.J., and Sessa W.C. Acidic hydrolysis as a mechanism for the cleavage of the Glu298Asp-variant of human endothelial nitric oxide synthase. J Biol Chem 30 (2001) 30
25. Hingorani A.D. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 154 (2001) 521-527
26. Gabriel S.B., Schaffner S.F., Nguyen H., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229